Parasitic infections remain a challenge in veterinary medicine. For pharmaceutical manufacturers, Levamisole HCl [1] API offers a reliable solution. It eliminates internal parasites and supports immune function, making it a preferred active ingredient in livestock anthelmintic formulations.
Levamisole hydrochloride (API grade) is a widely used veterinary active pharmaceutical ingredient (API) known for its efficacy against nematode infections. It supports consistent formulation performance and meets international regulatory standards.
Table of Contents
What Is Levamisole HCl and How Is It Used in Veterinary Pharmaceutical Manufacturing?
We use Levamisole HCl in various veterinary dosage forms, including oral solutions, injectables, and feed premixes. Its high water solubility and chemical stability support broad application across livestock segments.
Key Characteristics: A white crystalline powder, water-soluble (210 g/L at 20°C), with a molecular weight of 240.8 g/mol. Stable when protected from light and stored under controlled conditions.
Industry Application: Since its development in the 1960s, Levamisole HCl has been widely adopted in antiparasitic formulations[2]. It offers both anthelmintic and immunomodulatory benefits, adding value in integrated parasite control strategies.
Regulatory Compliance: Supplied under GMP standards[3]. Each batch typically includes COA, MSDS, and, when required, DMF or CTD documentation. Optical purity and impurity profile are closely monitored to meet pharmacopeial standards.
How Does Levamisole HCl Work-and Why Does It Matter to Formulators?
Levamisole HCl targets nematodes by disrupting their neuromuscular function. It binds to nicotinic acetylcholine receptors, causing sustained depolarization and spastic paralysis. Parasites are expelled naturally through peristalsis.
Its selectivity for parasite receptors ensures a favorable safety profile. This targeted action allows for effective treatment without compromising host safety.
In addition, Levamisole HCl enhances immune responses by activating T-cells and macrophages. This immune stimulation supports faster recovery and improves resistance to reinfection.
Pharmacokinetically, it absorbs rapidly and distributes efficiently in tissues. It metabolizes in the liver and clears through urine, minimizing residue concerns.
What Parasites Does Levamisole HCl Target-and What’s the Formulation Implication?
Levamisole HCl shows high efficacy against gastrointestinal and respiratory nematodes. Common targets include Haemonchus, Ostertagia, Trichostrongylus, Cooperia, and Dictyocaulus. It also controls Strongyloides and Oesophagostomum with moderate success.
It has limited or no effect on tapeworms, flukes, or external parasites. For broader parasite coverage, it can be combined with other actives.
Formulators benefit from its consistent performance in monotherapy and as part of fixed-dose combinations. Understanding its spectrum enables precise targeting in multi-active formulations.
Why Do Cattle and Sheep Formulators Prefer Levamisole HCl API?
Levamisole HCl supports measurable improvements in livestock performance. In ruminants, it contributes to better feed efficiency, faster weight gain, and improved reproductive outcomes.
Documented benefits include:
Average daily gain increase: 8–18%
Feed conversion improvement: up to 15%
Milk yield and wool quality enhancement
Its immunomodulatory action enhances vaccine response and reduces vulnerability to secondary infections. These benefits support higher productivity and reduced treatment frequency.
With fast onset and short withdrawal periods, it fits well into routine health programs. Its compatibility with strategic deworming enhances herd health and limits resistance.
How Should Manufacturers Handle Levamisole HCl in Formulations Safely?
Levamisole HCl suits a wide range of formulations. Common forms include oral solutions (75–150 mg/mL), injectables (50–100 mg/mL SC), and feed premixes.
Safe formulation begins with precise weighing and blending. Equipment must be calibrated to ensure uniform distribution. Withdrawal times must align with local regulations and product labeling.
Each batch should include validated documents: COA, MSDS, stability data, and technical dossiers where required. This supports compliance across diverse regulatory markets.
What Is the Typical Dosage Range for Different Species?
| Species | Dosage (mg/kg) | Route | Notes |
|---|---|---|---|
| Cattle | 7.5–8 | Oral/Injectable | Effective against Ostertagia |
| Sheep | 7.5–8 | Oral/Injectable | Adjust for narrow safety margin |
| Goats | 8–12 | Oral | Higher metabolic clearance rate |
| Pigs | 8 | Oral/Feed | Dose-formulation dependent |
| Poultry | 20–40 | Water | Adjust for intake behavior |
Formulators should confirm species-specific pharmacokinetics and include safety margins as needed.
Can Levamisole HCl Be Incorporated in Poultry Formulations?
Levamisole HCl works well in water-soluble poultry formulations. It targets Ascaridia galli, Heterakis gallinarum, and Capillaria spp. with high efficacy.
In layers and breeders, it supports improved feed conversion, egg production, and shell quality. In broilers, it enhances growth and flock uniformity.
Formulators typically use soluble powders administered through drinking water. Stability for 24-hour use is essential. Withdrawal periods are minimal-usually 3–5 days for meat and none for eggs.
What Side Effects Should Formulators Be Aware Of?
Levamisole HCl is generally well tolerated. Mild, transient reactions include salivation, restlessness, and soft stool. These resolve without intervention.
Overdose may cause cholinergic symptoms such as tremors or collapse. Proper dosing protocols mitigate this risk.
Formulators should ensure clear instructions on dosage and administration. Packaging and labeling should reinforce safety practices.
How Does Levamisole HCl Compare to Ivermectin and Other API Options?
| Attribute | Levamisole HCl | Ivermectin | Albendazole |
|---|---|---|---|
| Mechanism | nAChR agonist | Cl-channel opener | Microtubule inhibitor |
| GI Nematodes | High | High | High |
| Ectoparasites | None | Yes | None |
| Withdrawal Period | Short | Long | Moderate |
| Immune Benefit | Yes | No | No |
| Cost | Low | Moderate | Low |
Levamisole HCl remains a practical choice in resistance rotation strategies. It also fits well in programs requiring short withdrawal and rapid action.
Is Levamisole HCl a Cost-Effective API for Veterinary Manufacturers?
Levamisole HCl balances price, performance, and compliance. It supports high-margin, high-volume formulations across ruminants, swine, and poultry.
Key advantages include:
Low API cost per dose
Proven field efficacy
Compatibility with diverse dosage forms
Regulatory readiness
Its global availability ensures reliable sourcing. Manufacturers benefit from predictable lead times and full documentation support.
Used strategically, it reduces retreatment needs and supports long-term cost control.
Conclusion
Levamisole HCl (API grade) is a dependable choice for veterinary manufacturers developing nematode-targeting products. It delivers consistent efficacy, immune support, and regulatory alignment. With broad species applicability and proven performance, it remains a key component in modern antiparasitic drug development.
We offer GMP-grade Levamisole HCl API with full documentation. Contact us to discuss your formulation needs.
[1] Explore this link to understand the diverse applications and advantages of Levamisole HCl in veterinary practices, enhancing animal health.
[2] Discover cutting-edge research and innovations in antiparasitic formulations that can improve livestock health and productivity.
[3] Learn about GMP standards to ensure quality and safety in veterinary products, crucial for maintaining animal health and compliance.
